Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jan;39(1):70–74. doi: 10.1128/aac.39.1.70

Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.

I Muraoka 1, T Hasegawa 1, M Nadai 1, L Wang 1, S Haghgoo 1, O Tagaya 1, T Nabeshima 1
PMCID: PMC162487  PMID: 7695332

Abstract

Eisai hyperbilirubinemic mutant rats (EHBRs) with conjugated hyperbilirubinemia were recently derived from Sprague-Dawley rats (SDRs). The pharmacokinetic characteristics of the beta-lactam antibiotic cefpiramide (CPM), which is mainly excreted into bile, were investigated in 10- and 20-week-old EHBRs and were compared with those in 20-week-old healthy SDRs. The pharmacokinetic parameters of CPM after an intravenous administration of 20 mg/kg of body weight were estimated for each rat by noncompartmental methods. When compared with age-matched healthy SDRs, significant decreases (by approximately 30%) in the systemic clearance of CPM were observed in 20-week-old EHBRs. The biliary clearance of CPM in 20-week-old EHBRs markedly decreased to less than 10% of that in age-matched healthy SDRs, while total urinary recovery of unchanged CPM increased to threefold and renal clearance doubled. However, no significant differences in any of the pharmacokinetic parameters of CPM were observed between the two groups of EHBRs. There were no significant differences among the three groups in the steady-state volume of distribution of CPM. The present study indicates that hyperbilirubinemia induces an increase in the urinary excretion ability of CPM in return for a reduction in the biliary excretion.

Full Text

The Full Text of this article is available as a PDF (219.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barza M., Brusch J., Bergeron M. G., Kemmotsu O., Weinstein L. Extraction of antibiotics from the circulation by liver and kidney: effect of probenecid. J Infect Dis. 1975 May;131 (Suppl):S86–S97. doi: 10.1093/infdis/131.supplement.s86. [DOI] [PubMed] [Google Scholar]
  2. Brodersen R. Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem. 1979 Apr 10;254(7):2364–2369. [PubMed] [Google Scholar]
  3. Brodersen R., Honoré B., Larsen F. G. Serum albumin--a non-saturable carrier. Acta Pharmacol Toxicol (Copenh) 1984 Feb;54(2):129–133. doi: 10.1111/j.1600-0773.1984.tb01906.x. [DOI] [PubMed] [Google Scholar]
  4. DUBIN I. N., JOHNSON F. B. Chronic idiopathic jaundice with unidentified pigment in liver cells; a new clinicopathologic entity with a report of 12 cases. Medicine (Baltimore) 1954 Sep;33(3):155–197. doi: 10.1097/00005792-195409000-00001. [DOI] [PubMed] [Google Scholar]
  5. Eng C., Javitt N. B. Effect of nafcillin on hepatic excretory function. Biochem Pharmacol. 1983 Dec 1;32(23):3649–3651. doi: 10.1016/0006-2952(83)90317-9. [DOI] [PubMed] [Google Scholar]
  6. Fernández-Checa J. C., Takikawa H., Horie T., Ookhtens M., Kaplowitz N. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J Biol Chem. 1992 Jan 25;267(3):1667–1673. [PubMed] [Google Scholar]
  7. Hosokawa S., Tagaya O., Mikami T., Nozaki Y., Kawaguchi A., Yamatsu K., Shamoto M. A new rat mutant with chronic conjugated hyperbilirubinemia and renal glomerular lesions. Lab Anim Sci. 1992 Feb;42(1):27–34. [PubMed] [Google Scholar]
  8. Huber M., Guhlmann A., Jansen P. L., Keppler D. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology. 1987 Mar-Apr;7(2):224–228. doi: 10.1002/hep.1840070204. [DOI] [PubMed] [Google Scholar]
  9. Ishikawa T., Müller M., Klünemann C., Schaub T., Keppler D. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J Biol Chem. 1990 Nov 5;265(31):19279–19286. [PubMed] [Google Scholar]
  10. Jacobsen J., Fedders O. Determination of non-albumin-bound bilirubin in human serum. Scand J Clin Lab Invest. 1970 Nov;26(3):237–241. doi: 10.3109/00365517009046228. [DOI] [PubMed] [Google Scholar]
  11. Jansen P. L., Peters W. H., Lamers W. H. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology. 1985 Jul-Aug;5(4):573–579. doi: 10.1002/hep.1840050408. [DOI] [PubMed] [Google Scholar]
  12. Jansen P. L., Peters W. H., Meijer D. K. Hepatobiliary excretion of organic anions in double-mutant rats with a combination of defective canalicular transport and uridine 5'-diphosphate-glucuronyltransferase deficiency. Gastroenterology. 1987 Nov;93(5):1094–1103. doi: 10.1016/0016-5085(87)90574-9. [DOI] [PubMed] [Google Scholar]
  13. Kimura T., Yamao T., Nakayama S., Honge S., Kawakami T., Kurosaki Y., Nakayama T. Pharmacokinetics of cefpiramide in rats with obstructive jaundice. J Pharmacobiodyn. 1988 Dec;11(12):839–848. doi: 10.1248/bpb1978.11.839. [DOI] [PubMed] [Google Scholar]
  14. Kitamura T., Jansen P., Hardenbrook C., Kamimoto Y., Gatmaitan Z., Arias I. M. Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR-) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci U S A. 1990 May;87(9):3557–3561. doi: 10.1073/pnas.87.9.3557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kobayashi K., Sogame Y., Hara H., Hayashi K. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J Biol Chem. 1990 May 15;265(14):7737–7741. [PubMed] [Google Scholar]
  16. Kuipers F., Radominska A., Zimniak P., Little J. M., Havinga R., Vonk R. J., Lester R. Defective biliary secretion of bile acid 3-O-glucuronides in rats with hereditary conjugated hyperbilirubinemia. J Lipid Res. 1989 Dec;30(12):1835–1845. [PubMed] [Google Scholar]
  17. Matsui H., Yano K., Okuda T. Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys. Antimicrob Agents Chemother. 1982 Aug;22(2):213–217. doi: 10.1128/aac.22.2.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nadai M., Hasegawa T., Muraoka I., Takagi K., Nabeshima T. Dose-dependent pharmacokinetics of enprofylline and its renal handling in rats. J Pharm Sci. 1991 Jul;80(7):648–652. doi: 10.1002/jps.2600800707. [DOI] [PubMed] [Google Scholar]
  19. Nadai M., Hasegawa T., Wang L., Tagaya O., Nabeshima T. Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats. Drug Metab Dispos. 1994 Jul-Aug;22(4):561–565. [PubMed] [Google Scholar]
  20. Nishida T., Gatmaitan Z., Che M., Arias I. M. Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6590–6594. doi: 10.1073/pnas.88.15.6590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Oude Elferink R. P., de Haan J., Lambert K. J., Hagey L. R., Hofmann A. F., Jansen P. L. Selective hepatobiliary transport of nordeoxycholate side chain conjugates in mutant rats with a canalicular transport defect. Hepatology. 1989 Jun;9(6):861–865. doi: 10.1002/hep.1840090612. [DOI] [PubMed] [Google Scholar]
  22. Polhuijs M., Kuipers F., Vonk R. J., Mulder G. J. Stereoselectivity of glutathione conjugation: blood elimination of alpha-bromoisovalerylurea enantiomers and biliary excretion of the conjugates in unanesthetized normal or congenitally jaundiced rats. J Pharmacol Exp Ther. 1989 Jun;249(3):874–878. [PubMed] [Google Scholar]
  23. Sathirakul K., Suzuki H., Yasuda K., Hanano M., Tagaya O., Horie T., Sugiyama Y. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. J Pharmacol Exp Ther. 1993 Jun;265(3):1301–1312. [PubMed] [Google Scholar]
  24. Sawada Y., Hanano M., Sugiyama Y., Iga T. Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. J Pharmacokinet Biopharm. 1984 Jun;12(3):241–261. doi: 10.1007/BF01061720. [DOI] [PubMed] [Google Scholar]
  25. Takikawa H., Sano N., Narita T., Uchida Y., Yamanaka M., Horie T., Mikami T., Tagaya O. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology. 1991 Aug;14(2):352–360. [PubMed] [Google Scholar]
  26. Tamai I., Maekawa T., Tsuji A. Membrane potential-dependent and carrier-mediated transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver plasma membrane vesicles. J Pharmacol Exp Ther. 1990 May;253(2):537–544. [PubMed] [Google Scholar]
  27. Tanaka H., Nishino H., Sawada T., Kawaguchi N., Azuma T., Yoshii Y., Satake K. Biliary penetration of cefbuperazone in the presence and absence of obstructive jaundice. J Antimicrob Chemother. 1987 Sep;20(3):417–420. doi: 10.1093/jac/20.3.417. [DOI] [PubMed] [Google Scholar]
  28. Terasaki T., Tamai I., Takanosu K., Nakashima E., Tsuji A. Kinetic evidence for a common transport route of benzylpenicillin and probenecid by freshly prepared hepatocytes in rats. Influence of sodium ion, organic anions, amino acids and peptides on benzylpenicillin uptake. J Pharmacobiodyn. 1986 Jan;9(1):18–28. doi: 10.1248/bpb1978.9.18. [DOI] [PubMed] [Google Scholar]
  29. Tsuji A., Terasaki T., Takanosu K., Tamai I., Nakashima E. Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Evidence for a carrier-mediated transport system. Biochem Pharmacol. 1986 Jan 15;35(2):151–158. doi: 10.1016/0006-2952(86)90508-3. [DOI] [PubMed] [Google Scholar]
  30. Tsunekawa Y., Hasegawa T., Nadai M., Takagi K., Nabeshima T. Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives. J Pharm Pharmacol. 1992 Jul;44(7):594–599. doi: 10.1111/j.2042-7158.1992.tb05471.x. [DOI] [PubMed] [Google Scholar]
  31. Wright W. E., Line V. D. Biliary excretion of cephalosporins in rats: influence of molecular weight. Antimicrob Agents Chemother. 1980 May;17(5):842–846. doi: 10.1128/aac.17.5.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn. 1981 Nov;4(11):879–885. doi: 10.1248/bpb1978.4.879. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES